4.5 Letter

Impact of cerebral venous sinus thrombosis associated with COVID-19

Related references

Note: Only part of the references are listed.
Review Clinical Neurology

Cerebral venous thrombosis and severe acute respiratory syndrome coronavirus-2 infection: A systematic review and meta-analysis

Tommaso Baldini et al.

Summary: This study identified a low number of cases of CVT associated with COVID-19, with symptoms mainly occurring after respiratory disease and involving multiple sites. The occurrence rate of CVT in hospitalized patients with COVID-19 is low but requires a high level of suspicion, as diagnosing this potentially life-threatening condition in COVID-19 patients can be challenging.

EUROPEAN JOURNAL OF NEUROLOGY (2021)

Article Cardiac & Cardiovascular Systems

Incidence of Venous Thromboembolism and Mortality in Patients with Initial Presentation of COVID-19

Dimitrios Giannis et al.

Summary: VTE and mortality rates are over 1.0% in COVID-19 patients, with a higher proportion of males and older patients. Common comorbidities include hypertension and diabetes. The use of statins and antiplatelet medications is associated with reduced VTE and mortality risk for these patients.

JOURNAL OF THROMBOSIS AND THROMBOLYSIS (2021)

Article Clinical Neurology

SARS-CoV-2 and Stroke in a New York Healthcare System

Shadi Yaghi et al.

STROKE (2020)

Review Cardiac & Cardiovascular Systems

COVID-19 and Thrombotic or Thromboembolic Disease: Implications for Prevention, Antithrombotic Therapy, and Follow

Behnood Bikdeli et al.

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2020)

Review Neurosciences

Cerebral Venous Thrombosis in Patients with COVID-19 Infection: a Case Series and Systematic Review

Tian Ming Tu et al.

JOURNAL OF STROKE & CEREBROVASCULAR DISEASES (2020)

Article Clinical Neurology

Cerebral venous sinus thrombosis associated with SARS-CoV-2; a multinational case series

Ashkan Mowla et al.

JOURNAL OF THE NEUROLOGICAL SCIENCES (2020)